Pristiq
NDC 54868-2932
Product Information
Pristiq is a NDA-approved product labeled by Physicians Total Care, Inc.. Desvenlafaxine is used to treat depression. It is supplied as a pink product. This product entry covers the primary NDC 54868-2932 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
W;50
Code Structure Chart
Product Details
What is NDC 54868-2932?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DESVENLAFAXINE SUCCINATE (UNII: ZB22ENF0XR)
- DESVENLAFAXINE (UNII: NG99554ANW) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- TALC (UNII: 7SEV7J4R1U)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- POLYVINYL ALCOHOL (UNII: 532B59J990)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- HYPROMELLOSE 2208 (15000 MPA.S) (UNII: Z78RG6M2N2)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 1874559 - desvenlafaxine succinate 50 MG 24HR Extended Release Oral Tablet
- RxCUI: 1874559 - 24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet
- RxCUI: 1874559 - desvenlafaxine 50 MG (as desvenlafaxine succinate 76 MG) 24HR Extended Release Oral Tablet
- RxCUI: 790290 - Pristiq 50 MG 24HR Extended Release Oral Tablet
- RxCUI: 790290 - 24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet [Pristiq]
* Please review the full disclaimer at the bottom of this page.